4 recruiting, 2 not yet recruiting, 1 completed. 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow CIDP - Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of CIDP - Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy Xsens motion suit - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Not yet recruiting | Heinrich-Heine University, Duesseldorf | 50 | 2026-10-01 | 2026-10-20 | |
| Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting | Heinrich-Heine University, Duesseldorf | 35 | 2026-01-15 | 2026-06-10 | |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 218 | 2025-08-22 | 2026-10-16 |
| Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome (GBS) | Not yet recruiting | University of Erlangen-Nürnberg Medical School | 30 | 2025-08-06 | 2025-08-14 | |
| A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP KINE-101 - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 1 | Completed | Kine Sciences Co., Ltd. | 9 | 2024-08-27 | 2026-01-20 |
| A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding. Efgartigimod - Myasthenia Gravis, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting | argenx | 279 | 2023-11-30 | 2026-02-17 | |
| Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) Immunoglobulin - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 4 | Recruiting | University of Aarhus | 60 | 2020-06-04 | 2024-05-17 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (7) · Guillain-Barre Syndrome (1) · Myasthenia Gravis (1)
Autoimmune Diseases (7) · Autoimmune Diseases of the Nervous System (7) · Chronic Disease (7) · Demyelinating Diseases (7) · Disease Attributes (7) · Immune System Diseases (7) · Nervous System Diseases (7) · Neuromuscular Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Peripheral Nervous System Diseases (7) · Polyneuropathies (7) · Polyradiculoneuropathy (7) · Neoplasms (1) · Neoplasms by Site (1)
Immunoglobulins (1) · Immunoglobulins, Intravenous (1) · efgartigimod alfa (1)
Heinrich-Heine University, Duesseldorf (2) · argenx (2) · Kine Sciences Co., Ltd. (1) · University of Aarhus (1) · University of Erlangen-Nürnberg Medical School (1)
Germany (4) · Italy (2) · South Korea (2) · Spain (2) · United States (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Colombia (1) · Czechia (1) · Denmark (1) · Estonia (1) · France (1)
Hanna Park (1) · Henning Andersen, MD,DMSc,PhD (1) · Marc G Pawlitzki, PD Dr. med. (1)
2018 (1)